title: Effects of drug countermeasures for space motion sickness on working memory in humans.
authors.affiliation: Behavioral Toxicology Laboratories, Division of Neurotoxicology, HFT-132, USFDA's National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079-9502, USA. mpaule@nctr.fda.gov
authors.forename: Merle G
authors.initials: MG
authors.lastname: Paule
authors.forename: John J
authors.initials: JJ
authors.lastname: Chelonis
authors.forename: Donna J
authors.initials: DJ
authors.lastname: Blake
authors.forename: John L
authors.initials: JL
authors.lastname: Dornhoffer
mesh_terms: D000328:Adult; D000932:Antiemetics / Q000009:adverse effects* / Q000627:therapeutic use; D003072:Cognition Disorders / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008140:Lorazepam / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008468:Meclizine / Q000009:adverse effects / Q000627:therapeutic use; D008569:Memory Disorders / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control; D008570:Memory, Short-Term / Q000187:drug effects* / Q000502:physiology; D009483:Neuropsychological Tests; D011398:Promethazine / Q000009:adverse effects / Q000627:therapeutic use; D012399:Rotation / Q000009:adverse effects; D012601:Scopolamine / Q000009:adverse effects / Q000627:therapeutic use; D018489:Space Motion Sickness / Q000188:drug therapy* / Q000503:physiopathology; D014722:Vestibule, Labyrinth / Q000187:drug effects* / Q000503:physiopathology
chemical_list: D000932:Antiemetics; D008468:Meclizine; D012601:Scopolamine; D011398:Promethazine; D008140:Lorazepam
keywords: NASA Discipline Neuroscience; Non-NASA Center